BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 106198
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.106198
Table 2 Clinicopathological characteristics before and after propensity score-matching adjusting for major clinical parameters including sex, age, pathological T stage, pathological N stage, reconstructive techniques and laparoscopic approach
VariablesBefore PSM
After PSM
NAFLD (n = 52)
Controls (n = 1070)
P value
SMD
NAFLD (n = 52)
Controls (n = 208)
P value
SMD
Surgery time (minutes), mean (SD)198.9 (52.7)189.2 (46.5)0.1440.195198.9 (52.7)194.6 (47.1)0.7040.087
Complication0.9270.0460.6080.121
Yes (%)5 (9.6)118 (11.0)5 (9.6)28 (13.5)
No (%)47 (90.3)952 (89.0)47 (90.3)180 (86.5)
Complication (Grade III to V)10.05310.053
Yes (%)2 (3.8)31 (2.9)2 (3.8)6 (2.9)
No (%)50 (96.2)1039 (97.1)50 (96.2)202 (97.1)
T stage0.4380.3830.8860.171
T1 (%)32 (61.5)540 (50.5)32 (61.5)126 (60.6)
T2-3 (%)11 (21.1)370 (34.6)11 (21.1)48 (23.1)
T4 (%)9 (17.3)160 (15.0)9 (17.3)34 (16.3)
N stage0.028a0.5310.8090.176
N0 (%)38 (73.1)587 (54.9)38 (73.1)152 (73.1)
N1-2 (%)7 (13.5)288 (26.9)7 (13.5)30 (14.4)
N3 (%)7 (13.4)195 (18.2)7 (13.4)26 (12.5)
pTNM stage (AJCC 8th)0.1230.5020.8460.251
I A-B (%)34 (65.4)564 (52.7)34 (65.4)142 (68.3)
II A-B (%)8 (15.4)219 (20.5)8 (15.4)32 (15.4)
III A-C (%)10 (19.2)287 (26.8)10 (19.2)34 (16.3)
Neural invasion0.0670.3060.5210.133
Yes (%)9 (17.3)323 (30.2)9 (17.3)47 (22.6)
No (%)43 (82.7)747 (69.8)43 (82.7)161 (77.4)
Vascular invasion0.6870.0800.4790.135
Yes (%)14 (26.9)327 (30.6)14 (26.9)44 (21.2)
No (%)38 (73.1)743 (69.4)38 (73.1)164 (78.8)
Retrieved lymph nodes [mean (SD)]39.2 (12.3)42.5 (11.1)0.040a0.27939.2 (12.3)42.5 (12.5)0.0580.271
Positive lymph nodes [mean (SD)]3.4 (8.8)3.27 (6.1)0.8680.0203.4 (8.8)3.0 (7.0)0.9490.058
Positive lymph nodes rate [mean (SD)]0.56 (1.04)0.79 (1.02)0.1120.2240.56 (1.04)0.55 (1.02)0.9920.005


Write to the Help Desk